已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Mortality Trends of Idiopathic Pulmonary Fibrosis in the United States From 2004 Through 2017

医学 特发性肺纤维化 肺纤维化 纤维化 内科学
作者
Niranjan Jeganathan,Rory A. Smith,Matheni Sathananthan
出处
期刊:Chest [Elsevier BV]
卷期号:159 (1): 228-238 被引量:40
标识
DOI:10.1016/j.chest.2020.08.016
摘要

Background The burden of idiopathic pulmonary fibrosis (IPF)-related mortality in the United States in recent years is not well characterized. Research Question What are the trends in IPF-related mortality rates in the United States from 2004 through 2017? Study Design and Methods We used the Multiple Cause of Death Database available through the Centers for Disease Control and Prevention website, which contains data from all deceased US residents. IPF-related deaths were identified using International Classification of Diseases, 10th revision, codes. We examined annual trends in age-adjusted mortality rates stratified by age, sex, race, and state of residence. We also evaluated trends in place of death and underlying cause of death. Results From 2004 through 2017, the age-adjusted mortality decreased by 4.1% in men (from 75.5 deaths/1,000,000 in 2004 to 72.4 deaths/1,000,000 in 2017) and by 13.4% in women (from 46.3 deaths/1,000,000 in 2004 to 40.1 deaths/1,000,000 in 2017). This overall decrease was driven mainly by a decline in IPF-related mortality in patients younger than 85 years. The decreasing trend also was noted in all races except White men, in whom the rate remained stable. The most common cause of death was pulmonary fibrosis. The percentage of deaths occurring in the inpatient setting and nursing homes decreased, whereas the percentage of deaths occurring at home and hospice increased. Interpretation From 2004 through 2017, the IPF age-adjusted mortality rates decreased. This may be explained partly by a decline in smoking in the United States, but further research is needed to evaluate other environmental and genetic contributors. The burden of idiopathic pulmonary fibrosis (IPF)-related mortality in the United States in recent years is not well characterized. What are the trends in IPF-related mortality rates in the United States from 2004 through 2017? We used the Multiple Cause of Death Database available through the Centers for Disease Control and Prevention website, which contains data from all deceased US residents. IPF-related deaths were identified using International Classification of Diseases, 10th revision, codes. We examined annual trends in age-adjusted mortality rates stratified by age, sex, race, and state of residence. We also evaluated trends in place of death and underlying cause of death. From 2004 through 2017, the age-adjusted mortality decreased by 4.1% in men (from 75.5 deaths/1,000,000 in 2004 to 72.4 deaths/1,000,000 in 2017) and by 13.4% in women (from 46.3 deaths/1,000,000 in 2004 to 40.1 deaths/1,000,000 in 2017). This overall decrease was driven mainly by a decline in IPF-related mortality in patients younger than 85 years. The decreasing trend also was noted in all races except White men, in whom the rate remained stable. The most common cause of death was pulmonary fibrosis. The percentage of deaths occurring in the inpatient setting and nursing homes decreased, whereas the percentage of deaths occurring at home and hospice increased. From 2004 through 2017, the IPF age-adjusted mortality rates decreased. This may be explained partly by a decline in smoking in the United States, but further research is needed to evaluate other environmental and genetic contributors. The Promise (and Pitfalls) of Administrative Data for Idiopathic Pulmonary FibrosisCHESTVol. 159Issue 1PreviewReliable and current population-based estimates of idiopathic pulmonary fibrosis (IPF) mortality are needed to better understand the epidemiologic trends of IPF. This knowledge is key to informing IPF-related health policy, patient advocacy, and future research planning. Full-Text PDF
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
水若琳发布了新的文献求助10
4秒前
小黑完成签到,获得积分10
7秒前
8秒前
壮观的谷冬完成签到 ,获得积分0
8秒前
霸气的思柔完成签到,获得积分10
9秒前
aliu完成签到,获得积分10
10秒前
月儿完成签到 ,获得积分10
11秒前
牟翎完成签到,获得积分10
13秒前
liboshi完成签到,获得积分10
13秒前
霜鸣发布了新的文献求助10
15秒前
aliu发布了新的文献求助10
15秒前
andrele发布了新的文献求助10
18秒前
王子娇完成签到 ,获得积分10
19秒前
20秒前
传奇3应助霜鸣采纳,获得10
21秒前
hellokitty完成签到,获得积分10
21秒前
25秒前
852应助科研通管家采纳,获得10
25秒前
bkagyin应助科研通管家采纳,获得10
25秒前
JamesPei应助科研通管家采纳,获得10
25秒前
Rondab应助科研通管家采纳,获得10
25秒前
Rondab应助科研通管家采纳,获得10
25秒前
25秒前
wanci应助科研通管家采纳,获得30
25秒前
NexusExplorer应助科研通管家采纳,获得10
25秒前
bxxxxx应助科研通管家采纳,获得30
25秒前
搜集达人应助科研通管家采纳,获得30
25秒前
25秒前
生动丑应助科研通管家采纳,获得10
25秒前
zp6666tql完成签到 ,获得积分10
27秒前
李健的小迷弟应助maleo采纳,获得30
27秒前
LXY发布了新的文献求助10
28秒前
leyellows完成签到 ,获得积分10
29秒前
翟大有完成签到 ,获得积分0
29秒前
花花521完成签到,获得积分10
32秒前
欧阳完成签到 ,获得积分10
32秒前
傲娇的棉花糖完成签到 ,获得积分10
35秒前
苏小北完成签到 ,获得积分10
36秒前
shweah2003完成签到,获得积分0
38秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989972
求助须知:如何正确求助?哪些是违规求助? 3532034
关于积分的说明 11256042
捐赠科研通 3270884
什么是DOI,文献DOI怎么找? 1805093
邀请新用户注册赠送积分活动 882256
科研通“疑难数据库(出版商)”最低求助积分说明 809216